731 related articles for article (PubMed ID: 16033339)
21. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
22. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
Buchholz B; ;
Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
[No Abstract] [Full Text] [Related]
23. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
25. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
Onah HE; Ibeziako N; Nkwo PO; Obi SN; Nwankwo TO
J Obstet Gynaecol; 2008 Apr; 28(3):276-9. PubMed ID: 18569467
[TBL] [Abstract][Full Text] [Related]
26. Mothers' attitudes towards using services preventing mother-to-child HIV/AIDS transmission in Zimbabwe: an interview survey.
Chivonivoni C; Ehlers VJ; Roos JH
Int J Nurs Stud; 2008 Nov; 45(11):1618-24. PubMed ID: 18502426
[TBL] [Abstract][Full Text] [Related]
27. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
28. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
[TBL] [Abstract][Full Text] [Related]
29. Prevention of mother-to-child transmission of HIV: treatment options.
McIntyre J
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):971-80. PubMed ID: 16307509
[TBL] [Abstract][Full Text] [Related]
30. Elimination of HIV infection in infants in Europe--challenges and demand for response.
Ostergren M; Malyuta R
Semin Fetal Neonatal Med; 2006 Feb; 11(1):54-7. PubMed ID: 16377267
[TBL] [Abstract][Full Text] [Related]
31. Management of the infant born to a mother with HIV infection.
Havens PL; Waters D
Pediatr Clin North Am; 2004 Aug; 51(4):909-37, viii. PubMed ID: 15275981
[TBL] [Abstract][Full Text] [Related]
32. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission.
Villamor E; Aboud S; Koulinska IN; Kupka R; Urassa W; Chaplin B; Msamanga G; Fawzi WW
Eur J Clin Nutr; 2006 Jul; 60(7):862-9. PubMed ID: 16452912
[TBL] [Abstract][Full Text] [Related]
33. Preventing mother-to-child transmission of HIV: successes and challenges.
McIntyre J
BJOG; 2005 Sep; 112(9):1196-203. PubMed ID: 16101596
[TBL] [Abstract][Full Text] [Related]
34. Prevention of mother-to-child transmission of HIV--successes, controversies and critical questions.
Abrams EJ
AIDS Rev; 2004; 6(3):131-43. PubMed ID: 15595430
[TBL] [Abstract][Full Text] [Related]
35. [HIV and pregnancy].
Petry KU
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880
[TBL] [Abstract][Full Text] [Related]
36. Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa.
Giaquinto C
Scand J Infect Dis Suppl; 2003; 106():88-90. PubMed ID: 15000594
[TBL] [Abstract][Full Text] [Related]
37. Prevention of mother-to-child transmission of HIV in resource-rich and -poor settings.
Mepham SO; Bland RM; Newell ML
BJOG; 2011 Jan; 118(2):202-18. PubMed ID: 21040391
[TBL] [Abstract][Full Text] [Related]
38. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
39. Updated recommendations for reducing vertical HIV transmission.
Paul SM; Burr CK; DiFerdinando GT
N J Med; 2001 Sep; 98(9):35-8. PubMed ID: 11586883
[No Abstract] [Full Text] [Related]
40. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
